(Mostly) Asia-Pac M&A: TCM, Auswide, Latin Resources, Platinum Asset, Trancom, Pacific Smiles
This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...
428 Views
China TCM (570.HK) Privatization Update- Pre-Conditions Won't Be “An Obstacle” to the Entire Process
The applications have been submitted to SASAC/MOC/NDRC, and the Offeror/China TCM also modified the submitted documentation in light of the...
719 Views
Merger Arb Mondays (16 Sep) - China TCM, Canvest, GA Pack, Raysum, Seven & I, Fuji Soft, Dyna-Mac
This week, the highest gross spreads are HEC Pharma (139.1%), Raysum (94.2%), Canvest (8.4%), GAPack (7.3%), China TCM (6.5%), Henlius (6.3%),...
540 Views
China TCM (570.HK) Update - The Disappointing 24H1 Results Will Not Affect the Privatization Process
China TCM's weak 24H1 results may lead to negative growth in 2024,which however will help shareholder vote.Due to the low base, performance...
427 Views
TCM (570 HK): Profit Warning Is No Biggie
An eagle-eyed reader has flagged that SAMR appears to have accepted China Traditional Chinese Medicine (570 HK)'s fiing as a simplified case....
709 Views